Congestive Heart Failure Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure
Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024– Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 18, 2024 Category: Pharmaceuticals Source Type: clinical trials

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Conditions: Diabetes; Hypertension; High Cholesterol/Hyperlipidemia; Coronary Artery Disease; Congestive Heart Failure; Chronic Lung Disease; Chronic Kidney Diseases; Arrythmia; Stroke; Depression; Anxiety; Pulmonary Embolism; Heart Attack Interventions: Other: Med AAAction intervention Sponsors: University of Tennessee; Sponsor GmbH Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

The Level of sST2 in Pediatric Heart Failure
Conditions: Congenital Heart Disease; Congestive Heart Failure Interventions: Diagnostic Test: Suppression of tumorigenicity 2 (ST2) Sponsors: Eskisehir Osmangazi University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials

Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension
Conditions: Diabetes Mellitus; Chronic Obstructive Pulmonary Disease; Congestive Heart Failure; Myasthenia Gravis; Hypertension Interventions: Device: Medlink Sponsors: Olawuyi Racett Nigeria Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder
Conditions: Heart Failure; Overactive Bladder; Incontinence Interventions: Drug: Extended release torsemide; Drug: Immediate release torsemide; Drug: Extended release torsemide placebo; Drug: Immediate release torsemide placebo Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials

Bayer ’s AskBio initiates Phase II GenePHIT trial in Congestive Heart Failure (CHF)
Berlin, Germany/Research Triangle Park, North Carolina, USA, January 11, 2024– Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, have announced... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 11, 2024 Category: Pharmaceuticals Source Type: clinical trials

Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study
Conditions: Congestive Heart Failure Interventions: Device: Baroreflex Activation Therapy (BAT) Sponsors: Brian Houston; CVRx, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2024 Category: Research Source Type: clinical trials

Feasibility Study to Support Cardiorenal Function in Acute Decompensated Heart Failure With Diuretic Resistance
Conditions: Heart Failure; Acute Decompensated Heart Failure; Cardiorenal Syndrome; Heart Failure, Congestive; Heart Failure With Preserved Ejection Fraction; Heart Failure With Reduced Ejection Fraction; Diuretic Resistance Interventions: Device: ModulHeart Support Sponsors: Puzzle Medical Devices Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

A Pilot Observation and Feasibility Study of Prevora, Integrated Into Homecare Visits of High-risk Adults
Conditions: COPD (Chronic Obstructive Pulmonary Disease); CHF (Congestive Heart Failure); Dialysis; Chronic Metabolic Disorder Interventions: Drug: Prevora Sponsors: CHX Technologies Inc.; The Research Institute of St Joe ' s Hamilton; St. Joseph ' s Health System - Centre for Integrated Comprehensive Care Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials

the " Level of Resilience " Influencing Self-care in Heart Failure Patients
Conditions: Congestive Heart Failure Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials

CardioBreathApp vs IMT in Heart Failure
Conditions: Congestive Heart Failure Interventions: Device: Moment 1: IMT. Moment 2 CardioBreath.; Device: Moment 1: CardioBreath and moment 2: IMT. Sponsors: Instituto de Cardiologia do Rio Grande do Sul Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Care Transitions App for Patients With Multiple Chronic Conditions
Conditions: Heart Failure; Congestive Heart Failure; Diabetes; Diabetes Mellitus; Chronic Kidney Diseases Interventions: Behavioral: Care Transitions App Sponsors: Brigham and Women ' s Hospital; Agency for Healthcare Research and Quality (AHRQ) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
Condition: Cardiac Edema (CHF) Interventions: Drug: OPC 131461 10mg group; Drug: OPC 131461 5mg group; Drug: OPC 131461 2mg group; Drug: OPC 131461 1mg group; Drug: Placebo Sponsor: Otsuka Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2022 Category: Research Source Type: clinical trials